dichlororibofuranosylbenzimidazole has been researched along with Teratoma in 2 studies
Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.
Teratoma: A true neoplasm composed of a number of different types of tissue, none of which is native to the area in which it occurs. It is composed of tissues that are derived from three germinal layers, the endoderm, mesoderm, and ectoderm. They are classified histologically as mature (benign) or immature (malignant). (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1642)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, RS | 1 |
| Hodgson, M | 1 |
| Wang, SY | 1 |
| Gudas, LJ | 1 |
2 other studies available for dichlororibofuranosylbenzimidazole and Teratoma
| Article | Year |
|---|---|
Genetic markers in mouse teratocarcinoma cells. Selection and partial characterization of mutants resistant to toyocamycin, DRB and podophyllotoxin.
Topics: Adenosine Kinase; Animals; Cell Line; Dichlororibofuranosylbenzimidazole; Drug Resistance; Genetic M | 1981 |
Protein synthesis inhibitors prevent the induction of laminin B1, collagen IV (alpha 1), and other differentiation-specific mRNAs by retinoic acid in F9 teratocarcinoma cells.
Topics: Animals; Aphidicolin; Bucladesine; Cell Line; Collagen; Dichlororibofuranosylbenzimidazole; Diterpen | 1988 |